JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA.

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Adrenal incidentalomas are common adrenal lesions discovered incidentally.
• The Janus kinase 2 (JAK2) signaling pathway is implicated in various malignancies.
• The role of JAK2 mutations in adrenal tumors remains largely unexplored.

Purpose of the Study:

• To investigate the presence of JAK2 gene mutations in patients diagnosed with non-functioning adrenal incidentaloma (NFAI).
• To explore a potential genetic link between JAK2 signaling and the development of NFAI.

Main Methods:

• A cohort of 45 patients with NFAI and 45 healthy controls were recruited.
• Patients underwent tests to exclude functioning adrenal masses, including dexamethasone suppression tests and urinary metanephrine/normetanephrine analysis.
• JAK2 mutation analysis was performed on all NFAI patient samples.

Main Results:

• All 45 patients diagnosed with NFAI tested negative for JAK2 mutations.
• No JAK2 gene mutation positivity was detected in any of the analyzed samples.
• The study successfully excluded JAK2 mutations as a cause for NFAI in the studied cohort.

Conclusions:

• The JAK2 gene mutation was not found to be associated with non-functioning adrenal incidentaloma in this study.
• Further research is required to elucidate the underlying mechanisms and potential genetic factors contributing to adrenal incidentaloma.
• Additional clinical studies are necessary to explore other etiological pathways for NFAI.